858 THERAPEUTICS, INC.
Profile
Company Names
858 THERAPEUTICS, INC.
Addresses
3115 MERRYFIELD ROW, SUITE 110, SAN DIEGO, CA 92121
4757 NEXUS CENTER DRIVE, SUITE 150, SAN DIEGO, CA 92121
Phone Numbers
858-987-8380
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$65,231,597.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-06-26
$25,175,501.00
$50,350,497.00
$25,174,996.00
Equity
2
2021-05-04
$20,000,001.00
$39,999,996.00
$19,999,995.00
Equity
1
2020-03-03
$20,056,095.00
$37,500,000.00
$17,443,905.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALI
BEHBAHANI
DIRECTOR
ROTATION MEDICAL INC
| DENALI MEDICAL II, INC.
| MINERVA SURGICAL INC
| PROSPEX MEDICAL III, INC.
| OCULEVE, INC.
| CVRX INC
| IVANTIS, INC.
| ADAPTIMMUNE LTD
| CARDIONOMIC, INC.
| CVRX, INC.
| SOLACE THERAPEUTICS INC
| CRISPR THERAPEUTICS AG
| OYSTER POINT PHARMA, INC.
| GENOCEA BIOSCIENCES, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| SPYGLASS OPHTHALMICS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| NEA BH SPV, L.P.
| NEA BH SPV II, L.P.
| MONTE ROSA THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| NEW ENTERPRISE ASSOCIATES 18, L.P.
| NEA 18 VENTURE GROWTH EQUITY, L.P.
| FIRSTLIGHT BIO, INC.
| NEXO THERAPEUTICS, INC.
| LAUNCHPAD THERAPEUTICS, INC.
| NEA SH SPV, L.P.
| SPYGLASSPHARMA, INC.
| NEA RP SPV, L.P.
| NEA CH SPV, L.P.
| NEA TS 2024 SPV, L.P.
| NEA SECONDARY OPPORTUNITY FUND, L.P.
| TUNE THERAPEUTICS, INC.
BRADLEY
J.
BOLZON
DIRECTOR
CLARE
OZAWA
DIRECTOR
INCEPTION IBD, INC.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VII, L.P.
| OYSTER POINT PHARMA, INC.
| 858 THERAPEUTICS, INC.
| LYCIA THERAPEUTICS, INC.
| JENGU THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| MARCH THERAPEUTICS, INC.
| LENZ THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
CARLO
RIZZUTO
DIRECTOR
VENATORX PHARMACEUTICALS, INC.
| QUENTIS THERAPEUTICS, INC.
| PANDION THERAPEUTICS, INC.
| PANDION THERAPEUTICS HOLDCO LLC
| GRAPHITE BIO, INC.
| CENTURY THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| JNANA THERAPEUTICS INC.
| NEXO THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| PEP2TANGO THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
